Hassan, M. S.; Jawad, A. M. Assessment of Pathological Response to Neoadjuvant Therapy: Comparison Between Pertuzumab-Based and Non-Pertuzumab Protocols in HER2-Positive Breast Cancer. MECOJ 2026, 2 (3), 1-9. https://doi.org/10.61706/MECOJ160229.